PGG β-GLUCAN WITH CARBOPLATIN, PACLITAXEL AND CETUXIMAB FOR CHEMOIMMUNOTHERAPY OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Schneller, F. [1 ]
Thomas, M. [2 ]
Sadjadian, P. [3 ]
Kollmeier, J. [4 ]
Bose, N. [5 ]
Antonysamy, M. [5 ]
Patchen, M. [6 ]
Lowe, J. [6 ]
Huhn, R. D. [7 ]
Mattson, P. [6 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, D-80290 Munich, Germany
[2] Heidelberg Univ, Thoraxklin, Heidelberg, Germany
[3] Johannes Wesling Klinikum Minden, Klin Hamatol Onkol, Minden, Germany
[4] Helios Clin Behring, Lung Clin Heckeshorn, Berlin, Germany
[5] Biothera Inc, Immunol R&D, Eagan, MN USA
[6] Biothera, Clin, Eagan, MN USA
[7] Biothera Inc, Pharma Clin Dev, Eagan, MN USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2014年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
100PD
引用
收藏
页码：S40 / S41
页数：2
相关论文
共 50 条
  • [1] Imprime PGG improves the efficacy of carboplatin, paclitaxel, and cetuximab chemoimmunotherapy of advanced non-small cell lung cancer (NSCLC).
    Thomas, Michael
    Sadjadian, Parvis
    Kollmeier, Jens
    Hao, Zhonglin
    Patchen, Myra
    Lowe, Jamie
    Mattson, Paulette
    Huhn, Richard D.
    Bose, Nandita
    Antonysamy, Mary
    Gargano, Michele
    Gordon, Keith
    Schneller, Folker
    CLINICAL CANCER RESEARCH, 2014, 20
  • [2] Tolerability and activity of weekly paclitaxel and carboplatin in advanced non-small cell lung cancer (NSCLC)
    Fabi, A
    De Marco, S
    Barduagni, M
    Gamucci, T
    Cortesi, E
    De Marinis, F
    Ferraresi, V
    Saltarelli, R
    Gabriele, A
    Accettura, C
    Cognetti, F
    ANNALS OF ONCOLOGY, 2000, 11 : 4 - 4
  • [3] Concurrent chemoradiotherapy with paclitaxel and carboplatin for locoregionally advanced non-small cell lung cancer (NSCLC)
    Kaplanova, J.
    Tomiskova, M.
    Babickova, L.
    Kadlec, B.
    Slampa, P.
    Skrickova, J.
    LUNG CANCER, 2006, 52 : S34 - S34
  • [4] Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown?
    Sgambato, Assunta
    Casaluce, Francesca
    Maione, Paolo
    Rossi, Antonio
    Ciardiello, Fortunato
    Gridelli, Cesare
    JOURNAL OF THORACIC DISEASE, 2014, 6 (06) : 578 - 580
  • [5] Review of paclitaxel/carboplatin in advanced non-small cell lung cancer
    Bonomi, P
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 55 - 59
  • [6] Carboplatin and Weekly Paclitaxel for the Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) During Pregnancy
    Azim, Hatem A., Jr.
    Scarfone, Giovanna
    Peccatori, Fedro A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (04) : 559 - 560
  • [7] Carboplatin and paclitaxel (Taxol®) for non-small cell lung cancer [NSCLC], a standard regimen?
    Pralong-Kohler, J
    Stupp, R
    Monnerat, C
    Bauer, J
    Stalder, M
    Perey, L
    Leyvraz, S
    ANNALS OF ONCOLOGY, 1998, 9 : 87 - 87
  • [8] Paclitaxel Carboplatin in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Kanat, Ozkan
    Cubukcu, Erdem
    Cubukcu, Sinem
    Aksoy, Savas
    Canhoroz, Mustafa
    Karadag, Oya
    Alkis, Nihan
    Manavolglu, Osman
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2012, 3 (03) : 293 - 295
  • [9] Paclitaxel and Carboplatin in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Sadic, Murat
    Alavi, Abass
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2016, 7
  • [10] S0536: Carboplatin, paclitaxel, cetuximab and bevacizumab followed by cetuximab and bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC), a SWOG phase II study
    Kim, Edward S.
    Herbst, Roy S.
    Moon, James
    Redman, Mary W.
    Dakhil, Shaker R.
    Hirsch, Fred R.
    Mack, Phil
    Franklin, Wilbur
    Kelly, Karen
    Gandara, David
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S455 - S455
12345